Community Acquired Pneumonia
Conditions
Interventions
experimental group:Chinese medicine granules
control group:placebo
Sponsors
The First Affiliated Hospital of Henan traditional Chinese Medicine University
Eligibility
Sex/Gender
All
Age
65 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Elderly patients with pneumonia (CAP) who meet CAP diagnostic criteria within 1 week after discharge; 2. In line with TCM syndrome differentiation of lung and spleen qi deficiency, phlegm dampness is unfinished, qi and yin deficiency, phlegm heat is not clear, etc; 3. Aged=65 years old; 4. Volunteer to accept treatment,and be able to take oral medication; 5. Sign the informed consent.;Inclusion criteria: 1. Elderly patients with pneumonia (CAP) who meet CAP diagnostic criteria within 1 week after discharge; 2. In line with TCM syndrome differentiation of lung and spleen qi deficiency, phlegm dampness is unfinished, qi and yin deficiency, phlegm heat is not clear, etc; 3. Aged=65 years old; 4. Volunteer to accept treatment,and be able to take oral medication; 5. Sign the informed consent.
Exclusion criteria
Exclusion criteria: 1. Elderly patients with severe pneumonia after discharge from hospital; 2. Patients with confusion, disturbance of consciousness, dementia, all kinds of mental illness; 3. Accompanied by pleural effusion, bronchiectasis, active tuberculosis or lung abscess,COPD patients at grade C and D; 4. Patients with long-term bedriddenness accompanied by neuromuscular diseases at risk of aspiration; 5. Accompanied by oncology, severe cardiovascular disease (AMI, grade 3 and above), and severe liver and kidney disease (Severe liver disease refers to cirrhosis, portal hypertension and variceal bleeding, severe kidney disease including dialysis, kidney transplantation); 6. Participating in clinical trials of other drugs,and known to be allergic to therapeutic drugs.;Exclusion criteria: 1. Elderly patients with severe pneumonia after discharge from hospital; 2. Patients with confusion, disturbance of consciousness, dementia, all kinds of mental illness; 3. Accompanied by pleural effusion, bronchiectasis, active tuberculosis or lung abscess,COPD patients at grade C and D; 4. Patients with long-term bedriddenness accompanied by neuromuscular diseases at risk of aspiration; 5. Accompanied by oncology, severe cardiovascular disease (AMI, grade 3 and above), and severe liver and kidney disease (Severe liver disease refers to cirrhosis, portal hypertension and variceal bleeding, severe kidney disease including dialysis, kidney transplantation); 6. Participating in clinical trials of other drugs,and known to be allergic to therapeutic drugs.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| readmission rate;;readmission rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| fatality rate;CURB65 score;clinical outcome reported by doctors;clinical outcome reported by patients;patient's efficacy satisfaction;quality of life;safety index;health economics Index;;fatality rate;CURB65 score;clinical outcome reported by doctors;clinical outcome reported by patients;patient's efficacy satisfaction;quality of life;safety index;health economics Index; | — |
Countries
China
Contacts
Public ContactWang Minghang;Wang Minghang ;
The First Affiliated Hospital of Henan traditional Chinese Medicine University;The First Affiliated Hospital of Henan traditional Chinese Medicine University
Outcome results
None listed